Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
BOSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ...
Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -0.367647058824 | 8.16 | 8.5555 | 8 | 96208 | 8.27865172 | CS |
| 4 | -1.23 | -13.141025641 | 9.36 | 9.53 | 8 | 194880 | 8.49363444 | CS |
| 12 | -0.59 | -6.76605504587 | 8.72 | 12.3782 | 8 | 215077 | 9.68725301 | CS |
| 26 | 0.56 | 7.39762219287 | 7.57 | 12.3782 | 6.8 | 185983 | 9.29325959 | CS |
| 52 | -0.65 | -7.40318906606 | 8.78 | 12.3782 | 6.63 | 175780 | 8.56059023 | CS |
| 156 | -8.22 | -50.2752293578 | 16.35 | 24.83 | 5.99 | 122784 | 10.13392271 | CS |
| 260 | -5.97 | -42.3404255319 | 14.1 | 26.16 | 5.99 | 125969 | 10.67704955 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
